A few days ago, millions around the world cheered when the US Food and Drug Administration (FDA) approved a treatment for vitiligo - a topical cream that can restore pigment with unprecedented ...

A man who developed vitiligo as a child said he would not use a controversial treatment that may come to the UK. Ruxolitinib works by removing white patches, but carries some potentially serious ...

In trials of the cream for vitiligo, some users developed ... which means that if one treatment worked well for one patient it might not work for another at all, says the British Association ...

Aside from vitiligo and eczema, Incyte is also developing the cream as a treatment for hidradenitis suppurativa, another immune-related skin condition that causes abscesses and scarring.

In Europe, ruxolitinib cream (Opzelura) is approved for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age[3]. On 2 December 2022 ...